Class IITerminatedD-0314-2015
Drug recall · December 31, 2014
MAYHEM capsules recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586 67805 7.
- Lots / codes
Lot#: CLM061114, Exp 06/16
- Quantity
- 990 bottles
- Company
- Chaotic Labz, Atkins, AR
- Distribution
- Nationwide.
- Initiated
- November 14, 2014 · Voluntary: Firm initiated
- Classified
- December 22, 2014
- Reported
- December 31, 2014
- Ended
- January 13, 2017
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.